The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Apr. 08, 2015
Applicant:

Neurovive Pharmaceutical Ab, Lund, SE;

Inventors:

Eskil Elmer, Lund, SE;

Magnus Joakim Hansson, Landskrona, SE;

Karl Henrik Johannes Ehinger, Lund, SE;

Steven Moss, Balsham, GB;

Assignee:

ABLIVA AB, Lund, SE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/265 (2006.01); C07C 327/28 (2006.01); C07C 327/34 (2006.01); C07C 327/32 (2006.01); A61K 45/06 (2006.01); C07C 327/30 (2006.01); A61K 31/155 (2006.01); A61K 31/22 (2006.01); C07D 211/76 (2006.01); A61P 11/00 (2006.01); A61P 9/00 (2006.01); A61P 21/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/265 (2013.01); A61K 31/155 (2013.01); A61K 31/22 (2013.01); A61K 45/06 (2013.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 21/00 (2018.01); C07C 327/28 (2013.01); C07C 327/30 (2013.01); C07C 327/32 (2013.01); C07C 327/34 (2013.01); C07D 211/76 (2013.01); C07C 2601/14 (2017.05); Y02A 50/30 (2018.01);
Abstract

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinateaimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.


Find Patent Forward Citations

Loading…